November 2, 2012 / 7:11 AM / 5 years ago

BRIEF-Hikma Pharma maintains 20 pct revenue growth target

LONDON, Nov 2 (Reuters) - Hikma Pharmaceuticals PLC : * Pleased to maintain our guidance for 2012 of around 20% group revenue growth * Continue to expect around 20% branded revenue growth for the full year * Global injectables business has been performing ahead of our expectations * Saw an initial pick up in our generics business in the beginning of the

second half

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below